Danaher Is Down 30% From Its Peak. July 21 Is the Reset.
A $9.9B Masimo deal, bioprocessing equipment orders up 30%, and the first full earnings test of the combined company.
A $9.9B Masimo deal, bioprocessing equipment orders up 30%, and the first full earnings test of the combined company.
A guidance miss sent the stock to a two-year low. The real story is what comes next.
A 2.8 trillion parameter model just triggered the second DeepSeek moment in 18 months.
With August earnings approaching and China export risk already priced in, NVDA may be the most misunderstood stock in the…
AI chip revenue up 143% year over year, a $100B+ 2027 target, and September 3 is the reset date.
Same earnings window, same sector, very different bets.
Pricing power is the single most durable competitive advantage in any market cycle.
What happens to SPCX after the mechanical flow ends is the only question that matters now.
The BOJ is at 1% and signaling more. The carry trade is bigger than ever.
The memory supercycle is creating extreme winners and losers at the same time.